Graft Versus Host Disease GvHD Treatment Market Volume Analysis, Segments, Value Share and Key Trends 2016-2026
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain types of white blood cells. This is caused due to the transplanted cells (graft) see recipient’s body (host) as exotic, thus transplanted cells attack the host body.
Graft versus Host disease occurs after a stem cell or bone marrow transplant. High dose treatment destroy cancer cells along with that it simultaneously destroys healthy cells. Stem cell and bone marrow transplant treatments are used in reconstructing damaged cells, surrounding cancer tumors. Normally after high dose treatment, patient receives bone marrow from a donor through drip which resumes production of blood cells. Graft versus Host Disease occurs when certain types of white blood cells. This is caused due to the transplanted cells (graft) see recipient’s body (host) as exotic, thus transplanted cells attack the host body.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Graft</strong> <strong>Versus</strong> <strong>Host</strong><br />
<strong>Disease</strong> <strong>GvHD</strong><br />
<strong>Treatment</strong> <strong>Market</strong><br />
<strong>Share</strong>, Global <strong>Trends</strong>,<br />
<strong>Analysis</strong>, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> Forecast,<br />
<strong>2016</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.<br />
We combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for<br />
our client.<br />
Research Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
Sector Coverage<br />
• Automotive <strong>and</strong> Transportation<br />
• Electronics, Semiconductor, <strong>and</strong> ICT<br />
• Retail <strong>and</strong> Consumer Products<br />
• Industrial Automation <strong>and</strong> Equipment<br />
• Chemicals & Materials<br />
• Food <strong>and</strong> Beverages<br />
• Services <strong>and</strong> Utilities<br />
• Energy, Mining, Oil, <strong>and</strong> Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Graft</strong> versus <strong>Host</strong> disease occurs after a stem cell or bone marrow transplant. High dose<br />
treatment destroy cancer cells along with that it simultaneously destroys healthy cells.<br />
Stem cell <strong>and</strong> bone marrow transplant treatments are used in reconstructing damaged<br />
cells, surrounding cancer tumors. Normally after high dose treatment, patient receives<br />
bone marrow from a donor through drip which resumes production of blood cells. <strong>Graft</strong><br />
versus <strong>Host</strong> <strong>Disease</strong> occurs when certain types of white blood cells. This is caused due to<br />
the transplanted cells (graft) see recipient’s body (host) as exotic, thus transplanted cells<br />
attack the host body.<br />
It is tough to diagnose who might develop <strong>GvHD</strong> after a transplant. Mild form of <strong>GvHD</strong> is<br />
observed in few cases. While in certain cases <strong>GvHD</strong> may be fatal. <strong>GvHD</strong> do not occur<br />
when recipient receives their own cells through autologous transplant. Prior to a<br />
transplant, cells from possible donors are screened to realize how strictly they match the<br />
recipient. Chances of <strong>GvHD</strong> are reduced, or symptoms will be milder, when the match is<br />
close.<br />
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/repgb-1401<br />
There are two forms of <strong>GvHD</strong>:<br />
• Acute graft versus host disease (a<strong>GvHD</strong>).<br />
• Chronic graft versus host disease (c<strong>GvHD</strong>).
Report Description<br />
<strong>Graft</strong> <strong>Versus</strong> <strong>Host</strong> <strong>Disease</strong> (<strong>GvHD</strong>) <strong>Treatment</strong> <strong>Market</strong>: Drivers <strong>and</strong> Restraints<br />
Presently, graft versus host disease (<strong>GvHD</strong>) market is driven by increase in number of<br />
incidence <strong>and</strong> prevalence of cancer patients which are treated by chemotherapy<br />
treatment. <strong>Graft</strong> versus host disease (<strong>GvHD</strong>) global market is also fueled by increase in<br />
number of bone marrow transplants been carried around the globe to treat specific types<br />
of cancers. Increase in allogeneic hematopoietic stem cell transplant will play key role in<br />
global market for graft versus host disease (<strong>GvHD</strong>). However, cost linked with recent<br />
clinical trials <strong>and</strong> authorizations would acts as a major restraint for graft versus host<br />
disease (<strong>GvHD</strong>) global market.<br />
<strong>Graft</strong> versus <strong>Host</strong> <strong>Disease</strong> (<strong>GvHD</strong>) <strong>Treatment</strong>: Segmentation<br />
Global <strong>Graft</strong> versus host disease (<strong>GvHD</strong>) marketis segmented into following product type,<br />
<strong>and</strong> region:<br />
Based on product type segment, global <strong>Graft</strong> versus host disease (<strong>GvHD</strong>) market is<br />
segmented into:<br />
• Monoclonal antibodies<br />
• mTOR inhibitors<br />
• Tyrosine kinase inhibitors
Report Description<br />
• Thalidomide<br />
• Etanercept<br />
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1401<br />
<strong>Graft</strong> versus <strong>Host</strong> <strong>Disease</strong> (<strong>GvHD</strong>) <strong>Treatment</strong> <strong>Market</strong>: Overview<br />
The global market graft versus host disease (<strong>GvHD</strong>) treatmentis expected to register a<br />
healthy CAGR during the forecast period. Innovative development of novel technologies,<br />
<strong>and</strong> increase in the number of cancer patients seeking for chemotherapy treatment is<br />
expected to drive the growth of graft versus host disease (<strong>GvHD</strong>) treatmentmarket in the<br />
forecast period (<strong>2016</strong>-<strong>2026</strong>).<br />
<strong>Graft</strong> versus <strong>Host</strong> <strong>Disease</strong> (<strong>GvHD</strong>) <strong>Treatment</strong> <strong>Market</strong>: Region-wise Outlook<br />
Depending on geographic regions, global medical graft versus host disease (<strong>GvHD</strong>)<br />
treatment marketis segmented into seven key regions: North America, Latin America,<br />
Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan <strong>and</strong> Middle East &<br />
Africa. In terms of region Europe holds for the largest market shares in global market<br />
graft versus host disease (<strong>GvHD</strong>) treatmentowing to improvements in medical research,<br />
clinical trials, growing geriatric population with cancer indication. Whereas, North<br />
America <strong>and</strong> Asia-Pacific is likely to grow at a substantial growth due to large incidence<br />
<strong>and</strong> prevalence of cancer patientswill contribute to the global graft versus host disease<br />
(<strong>GvHD</strong>) treatmentmarket value showing a healthy CAGR during the forecast period, <strong>2016</strong>-<br />
<strong>2026</strong>.
Report Description<br />
The market for graft versus host disease (<strong>GvHD</strong>) treatment in various regions is<br />
particularly driven by gradually increasing awareness, rising number of chemotherapies<br />
<strong>and</strong> adoption of advanced technologies in cancer treatment.<br />
Browse full report: http://www.futuremarketinsights.com/reports/graft-versus-hostdisease-gvhd-treatment-market<br />
<strong>Graft</strong> versus <strong>Host</strong> <strong>Disease</strong> (<strong>GvHD</strong>) <strong>Treatment</strong> <strong>Market</strong>: <strong>Key</strong> Players<br />
Some of the key participating global players in graft versus host disease (<strong>GvHD</strong>) treatment<br />
global market are Sanofi, Novartis AG, Neovii Biotech GmbH,Merck & Co., Astellas<br />
Pharma Inc.,Soligenix, Inc., Mesoblast Ltd <strong>and</strong> others.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact: Mr. Sudip Saha<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language